NCT04938843View on ClinicalTrials.gov

Effect of F. Prausnitzii on Glycemic Control

NAUnknownINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Pre DiabetesImpaired Glucose ToleranceNon-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

F. prausnitzii and D. piger

Dietary supplementation with capsules containing F. prausnitzii and D. piger once daily for 12 consecutive weeks

DIETARY_SUPPLEMENT

Placebo

Dietary supplementation with placebo capsules identical to those containing F. prausnitzii and D. piger once daily for 12 consecutive weeks

Trial Locations (1)

413 50

RECRUITING

Wallenberg Laboratory, University of Gothenburg, Gothenburg

Sponsors

Lead Sponsor

MetaboGen AB
All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

MetaboGen AB

INDUSTRY